Biocon Q4 net up three-fold at Rs 81 cr
Pharma major Biocon Ltd on Thursday posted an over three-fold jump in its consolidated net profit at Rs 81 crore for the fourth quarter ended March 2010, as against Rs 25 crore in the year-ago period.
Consolidated net sales of the biotechnology major rose to Rs 657 crore during the January-March quarter from Rs 466 crore in the year-ago period, the company said in a filing to the National Stock Exchange.
The Bangalore-based co pany has declared a dividend of 70 per cent or Rs 3.50 per share.
“We are confident of sustaining good growth momentum in the years ahead,” said Kiran Mazumdar-Shaw, chairman and managing director, Biocon Ltd.